CMP-VISUAL– AN INNOVATIVE SYSTEM FOR OBJECTIVE PERIMETRY & EARLY NON-INVASIVE DIAGNOSIS OF BRAIN NEURODEGENERATION (#2013012)

The Unmet Need:

Glaucoma and brain neurodegeneration diseases are leading cause for morbidity and carry an immense social and economic burden which is predicted to increase with the aging of the population and increase in patients' numbers worldwide. Currently diagnosis, disease progression monitoring and development of efficient intervention are limited by:

1. Lack of objective, reliable and sensitive testing of visual field
2. There is no test for early diagnosis of glaucoma.
3. Faster, easier and sensitive methods of visual field are needed by providers to supply care to increasing glaucoma populations.
4. No reliable, easily accessible, noninvasive sensitive tests for early diagnosis of brain neurodegeneration

The Innovation:

CMP-visual is an innovative diagnostic technology that enables for the first time to objectively measure the visual field (VF) & brain function through multidimensional analysis of the pupillary responses for focal chromatic light stimuli.  The novelty of CMP-visual:

1. Innovative technology for non-invasive mapping of retinal circuits with high spatial resolution
2. Groundbreaking objective VF testing
3. Objective assessment of visual acuity
4. Reliable & sensitive early diagnosis of glaucoma
5. Early diagnosis of brain pathologies (Alzheimer, Parkinson, brain tumors, TBI - Elevation in Intracranial pressure, ADHD) with high diagnostic accuracy

Key Advantages:

1. Objective, accurate & non-invasive, simple & reliable test
2. Outstanding ability to classify between patients and healthy individuals
3. Supported by substantial & compelling clinical data (>500 healthy subjects & patients) and publications at high impact factor journals (Ophthalmology, IOVS, TVST)
4. Protected by several patent families
5. Easy path to FDA & CE : Class I, 510(k)
6. Quick market entry
7. Untapped market: no objective test for VF loss, no test for early detection of glaucoma & brain pathologies
8. Fast growing market
9. Future applications in telemedicine: CMP mobile devices & cloud services

Potential Products:

Desk-top devices, Hand-held mobile devices, Test-on-a cloud service, Telemedicine

Potential Applications:

1. Objective perimetry and visual acuity testing
2. A screening test for early diagnosis of ophthalmic diseases, TBI and brain neurodegeneration diseases
3. Patients' monitoring and response to treatment